U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Unknown
139594
Name Type Language
Efpegerglucagon
INN  
Official Name English
Human immunoglobulin G4 Fc fragment (h-CH2-CH3-CHS domains [Homo sapiens IGHG4*01 (hinge (1-4), CH2 (5-114), CH3 (115-219), CHS (220-221))]) (1-221), disulfide bridged dimer, produced in Escherichia coli, with one Fc chain conjugated (P <sup>1</sup> →C
Common Name English
HM-15136
Code English
efpegerglucagon [INN]
Common Name English
HM15136
Code English
Classification Tree Code System Code
EU-Orphan Drug EU/3/18/2022
Created by admin on Sat Dec 16 15:18:29 GMT 2023 , Edited by admin on Sat Dec 16 15:18:29 GMT 2023
FDA ORPHAN DRUG 658818
Created by admin on Sat Dec 16 15:18:29 GMT 2023 , Edited by admin on Sat Dec 16 15:18:29 GMT 2023
Code System Code Type Description
FDA UNII
2CAH3OC0X5
Created by admin on Sat Dec 16 15:18:29 GMT 2023 , Edited by admin on Sat Dec 16 15:18:29 GMT 2023
PRIMARY
INN
12786
Created by admin on Sat Dec 16 15:18:29 GMT 2023 , Edited by admin on Sat Dec 16 15:18:29 GMT 2023
PRIMARY
CAS
2766774-81-4
Created by admin on Sat Dec 16 15:18:29 GMT 2023 , Edited by admin on Sat Dec 16 15:18:29 GMT 2023
PRIMARY
ACTIVE MOIETY
Efpegerglucagon
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966